Concepedia

Clarke Taylor

CT

Statistics

Publications

10

Citations

534

H-Index

10

Active since

2006

Affiliations

Lycera (United States)(Current)

Pfizer (United States)

University of Michigan

MUSC Hollings Cancer Center

Medical University of South Carolina

Clarke Taylor is an author at Lycera (United States) specializing in medicinal chemistry, drug discovery, and drug design.

Publications per year

2006–2021

10

Publications

10

Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors

Paul A. Renhowe, Sabina Pecchi, Cynthia M. Shafer et al. · Journal of Medicinal Chemistry · 2008 · 135 citations · Full text

, , +13

Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity

Xiao Hu, Xikui Liu, Jacques Moisan et al. · OncoImmunology · 2016 · 107 citations · Full text

, , +17

The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents

Sean T. Murphy, Heather L. Case, Edmund L. Ellsworth et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 88 citations · Full text

, , +17

Anaplerotic Metabolism of Alloreactive T Cells Provides a Metabolic Approach To Treat Graft-Versus-Host Disease

Gary D. Glick, Rodrigue Rossignol, Costas A. Lyssiotis et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 67 citations · Full text

, , +17

Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC

Joseph S. Warmus, Cheryl L. Quinn, Clarke Taylor et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 32 citations · Full text

, , +14

1–5 of 10